0.1-Hz rhythms, 701 25 hydroxy vitamin D, 434 ABCA1 gene variants,18 ABO blood group, 55 ACE inhibitors, 701 Acromegaly, 456
Acute coronary syndrome, 134, 505 Acute stress cardiomyopathy, 73 Ambulatory blood pressure, 711 Aminoguanidine, 679
Anatomy, 674 Angina pectoris, 156 Angiogenesis, 336
Angiotensin II receptor blocker, 685 Antihypertensive treatment, 363 Antioxidants, 229
Aorta, 679
Aortic aneurysm, 106 Aortic knob width, 68 Aortic regurgitation, 427 Arrhythmogenic mechanisms, 442 Arterial hypertension, 389, 701 Arterial stiffness, 456, 525 Arteriovenous fistula, 239, 542 Asymmetric dimethylarginine, 26 Atherosclerosis, 40, 150, 229, 357, 378, 456, 525 Atrial appendage function, 256
Atrial fibrillation, 68, 256 Atrial phasic functions, 719 Atrial septal defect, 417
Autonomic dysfunction, 525, 701 Autonomic nervous system, 413 Aviation, 150
Blood flow velocity, 286 Blood pressure, 685 BNP, 422
Body mass index, 140 Brachial artery, 685
Brain natriuretic peptide, 505 Breast calcification, 378 Cabergoline, 121 Calcitriol, 434
Cardiac autonomic functions, 735 Cardiac beta-myosin heavy chain, 244 Cardiac device infections, 76 Cardiac magnetic resonance, 442 Cardiac surgery, 274
Cardiac toxicity, 328
Cardiopulmonary exercise testing, 370 Cardiovascular events, 389
Carotid artery intima-media thickness, 464 Carotid intima-media thickness, 525 Carotid stiffness index, 464 Ceruloplasmin, 229 Children, 383
Chronic renal failure, 239, 280 Clopidogrel resistance, 134 Collateral arteries, 336 Collateral circulation, 48
Color Doppler ultrasonography, 286 Complete reverse remodeling, 73 Congenital heart diseases, 531
Contrast agent-induced nephropathy, 505 COPD, 370
Coronary angiography, 40, 150, 156, 505 Coronary artery bypass grafting, 286 Coronary artery bypass surgery, 68 Coronary artery disease, 55, 48, 351, 511 Coronary artery ectasia, 322
Coronary flow reserve, 342 Coronary heart disease risk, 18 Coronary risk factors, 150 Delayed enhancement, 442 Detrended fluctuation analysis, 3 Device related endocarditis, 76 Diabetes type-2, 26 Diabetes, 186, 322 Diabetes, 679 Diagnostic accuracy, 48, 68, 286, 351, 519, 719 Diagnostic value, 134 Dialysis, 280 Diastolic dysfunction, 256 , 280
Diastolic flow in the descending aorta, 427 Diastolic function, 251, 422
Dilated cardiomyopathy, 342, 434 Doppler ultrasonography, 378 Echocardiography, 9, 115, 265, 422 Endothelial biomarkers, 363
Endothelial nitric oxide synthase gene, 239 Epicardial fat tissue, 115
Essential hypertension, 3 Fibrosis, 328
Flow mediated vasodilatation, 363, 685 Flow-mediated dilation, 464
Fqrs, 450
Fragmented QRS complex, 450 Functional tricuspid regurgitation, 34 Gaiter area, 3 Gamma-glutamyl transferase, 48, 106 Gender difference, 18 Ghrelin, 234 Glucose, 26 Graft patency, 542 Heart failure, 178, 186, 519 Heart rate recovery, 351 Heart rate turbulence, 434
Heart rate variability, 413, 434, 525, 735 Heart, 328
Hemodialysis, 542 Hepcidin, 515
Home blood pressure, 711 Homocysteine, 357 Hormonotherapy, 328 Hypertension, 106, 186, 234, 251, 498, 692
14
th
Volume Index
SUBJECT INDEX
February 2014-December 2014
Hypertrophic cardiomyopathy, 244, 719 Iloprost, 383
Implantable cardioverter defibrillator, 76 Inflammation, 229, 515
Inflammatory markers, 336
Intercellular adhesion, molecule-1, 156 Internal thoracic artery, 286
Intima-media thickness, 378 Iodixanol, 156
Iopamidol, 156
Irritable bowel syndrome, 525 Isovolumic acceleration, 417 Left atrial function, 128 Left atrial systolic force, 280 Left atrium, 674
Left ventricle, 422
Left ventricular hypertrophy, 389 Left ventricular mass index, 234 LIMA, 172
Lipids, 498
Logistic regression analysis, 128 Long QT syndrome, 162 Masked hypertension, 357 Matrix metalloproteinases, 531 Mean platelet volume, 134, 728 Medication adherence, 692 Meta-analysis, 322 Metabolic syndrome, 128 Microalbuminuria, 505
Minimally invasive coronary revascularization, 172 Mitral valve replacement, 34
Mitral valve surgery, 61 Models of heart failure,178 Modules of failing myocardium, 178 Multiple logistic regression analysis, 55 Multislice computerized tomography, 150 Mutation, 244
Myocardial bridging, 40 Myocardial infarction, 515 Myocardial performance index, 450 Natriuretic peptides, 519, 719 Nephrotic syndrome, 450 Network cardiology, 178 Nitric oxide, 679 Nitroglycerin-induced vasodilatation, 685 Non-dipper hypertension, 251 NT-probnp, 370
Obstructive sleep apnea syndrome, 192, 265
Omentin, 511 Oval fossa, 674 Oxidative stress, 26, 48, 106, 498 P wave dispersion, 251 Pain, 140 Paraoxonase, 498 Paravalvular leak, 61 Parkinson disease, 121 Partial lower sternotomy, 172 Pathophysiology, 389 PCR-RFLP, 511
Peripheral vascular disease, 9 Permanent pacemaker, 76 Phospholipids, 18
Plasma asymmetric dimethylarginine, 491 Polymorphism, 239, 511
Positive continuous airway pressure therapy, 265 Predictive value, 274 Primary hyperaldosteronism,192 Pseudoexfoliation syndrome, 422 PTFE, 542 Pulmonary hypertension, 274, 370, 383, 531 Pulmonary veins, 674
Pulsed wave Doppler velocity, 427 QT prolongation, 162 Quality of life, 370 Radiotherapy, 328 Ramadan fasting, 413 Rat, 328, 679 RDW, 342
Regional preserved contractility, 18
Regression analysis, 9, 26, 40, 68, 18, 34, 48, 106, 336, 351, 498, 519 Renal failure, 519
Renal sympathetic denervation, 186 Renovascular disease, 192 Reoperation, 61
Resistant hypertension, 192 Restenosis, 491
Right ventricular dysfunction, 370 Right ventricular function, 417 ROC analysis, 342
Saphenous vein, 542 Scale, 692
Score for atherosclerosis, 9 Secondary hypertension, 192 Sensitivity and specificity, 286 Sensitivity, 106, 134, 351, 719
Septal band, 674 Sex difference, 26
Short-term disease course, 73 Sicam-1, 274 Skin blood flow, 3 Sleep apnea, 186
Specificity, 9, 106, 134, 351, 719 Speckle tracking echocardiography, 128 Stable angina pectoris, 336
Statins, 229 STEMI, 728 Stent, 491
Stress-induced cardiomyopathy, 162 ST-segment resolution, 728
Sudden cardiac death, 434 Survival analysis,172, 542 Svcam-1 , 274
SYNTAX score, 55 Systems biology, 178
Systolic and diastolic dysfunction, 265 T wave alternans, 442
Takotsubo cardiomyopathy, 162 Target organ damage, 711 Tei index, 450
Thrombosis, 239 Thrombus formation, 256 Tissue Doppler imaging, 417 Tissue Doppler, 265, 422
Tissue inhibitors of metalloproteinases, 531 Transcatheter closure, 417
Transient left ventricular ballooning syndrome, 162 Transposition of the great arteries, 735 Transradial approach, 140 Transthoracic echocardiography, 61 Trastuzumab, 328 Tricuspid annuloplasty, 34 Turkish population,18 Type 1 diabetes, 464 Type 2 diabetes mellitus, 505 Validity, 692
Valsartan, 234 Valvular, 121 VAS, 172
Vascular cell adhesion molecule-1, 156 Ventricular function, 121
Visual evoked potential, 498 Volar region,3
Wrist circumference, 140 α-smooth muscle actin, 679 β-blockers, 701
763
Anatol J Cardiol, Vol: 14, Issue: 8, December 2014
